HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Treatment of great hematoma in brain hemorrhage with multi-point puncture and continuous irrigation-draining]

AbstractOBJECTIVE: To investigate the clinical effect of multi-point aspiration combined with continuous irrigation with urokinase in treating great hematoma as the result of brain hemorrhage due to hypertension. METHODS: Ninety-four patients with great hematoma as the result of brain hemorrhage due to hypertension, aged 70, were randomly divided into 2 equal groups: one point puncture group and multi-point puncture group. Both groups underwent puncture under local or general anesthesia and were irrigated with urokinase continually. The outcomes were recorded and analyzed. RESULTS: The case-fatality rate of the multi-point puncture group was 10.87, significantly lower than that of the one-point puncture group (20.83, P < 0.05). The superiority rate of recovery of the multi-point group was 78.26%, significantly higher than that of the one-point puncture group (64.58%, P < 0.05). In 15 days, the resolution rate of brain hematoma of the multi-point group was 67.43%, significantly higher than that of the one point puncture group (23.68%, P < 0.01). The re-hemorrhage rate of the multi-point puncture group was 8.95%, significantly lower than that of the one-point puncture group (12.5%, P < 0.05). CONCLUSION: Multi-point puncture and continuous irrigation decrease the intracranial pressure quickly and suck the hematoma more effectively, especially for the great and irregular hematoma of brain. Continuous urokinase irrigation-drainage is able to keep the concentration of urokinase at an effective level, thus continuously washing, liquefying, draining, and resolving the brain hematoma.
AuthorsXiao-ming Huang, Shi-ping Chen, Wen Cheng, Xiao-dong Yuan, Wen-hua Tang (Affiliation: Department of Neurosurgery, Chengdu Railroad Central Hospital, Chengdu 610081, China.)
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 88 Issue 39 Pg. 2786-8 (Oct 28 2008) ISSN: 0376-2491 [Print] China
PMID19080457 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Fibrinolytic Agents
  • Urokinase-Type Plasminogen Activator
Topics
  • Aged
  • Aged, 80 and over
  • Female
  • Fibrinolytic Agents (administration & dosage)
  • Hematoma (therapy)
  • Humans
  • Intracranial Hemorrhage, Hypertensive (therapy)
  • Irrigation (methods)
  • Male
  • Middle Aged
  • Paracentesis
  • Urokinase-Type Plasminogen Activator (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD